Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing
Open accessAbstract
Biopharmaceuticals are of increasing importance in the treatment of a variety of diseases. A remaining concern associated with their production is the potential introduction of adventitious agents into their manufacturing process, which may compromise the pathogen safety of a product and potentially cause stock‐out situations for important medical supplies. To ensure the safety of biological therapeutics, regulatory guidance requires adventitious agent testing (AAT) of the bulk harvest. AAT is a deliberately promiscuous assay procedure which has been developed to indicate, ideally, the presence of any viral contaminant. One of the most important cell lines used in the production of biopharmaceuticals is Chinese hamster ovary (CHO) cells and while viral infections of CHO cells have occurred, a systematic screen of their virus susceptibility has never been published. We investigated the susceptibility of CHO cells to infection by 14 different viruses, including members of 12 families and representatives or the very species that were implicated in previously reported production cell infections. Based on our results, four different infection outcomes were distinguished, based on the possible combinations of the two factors (i) the induction, or not, of a cytopathic effect and (ii) the ability, or not, to replicate in CHO cells. Our results demonstrate that the current AAT is effective for the detection of viruses which are able to replicate in CHO cells. Due to the restricted virus susceptibility of CHO cells and the routine AAT of bulk harvests, our results provide re‐assurance for the very high safety margins of CHO cell‐derived biopharmaceuticals. Biotechnol. Bioeng. 2010;106: 598–607. © 2010 Wiley Periodicals, Inc.
AI snapshot
Written from the paper’s full text.
TL;DR
This study systematically screened Chinese hamster ovary (CHO) cells against 14 viruses from 12 families and found four distinct infection outcomes based on cytopathic effect (CPE) and replication. The authors conclude that routine adventitious agent testing (AAT) detects viruses able to replicate in CHO cells, supporting high safety margins for CHO-derived biopharmaceuticals.
Key findings
- CHO cells showed four outcomes: CPE plus replication/persistence (human adenovirus [hAdV], encephalomyocarditis virus [EMCV], mice minute virus [MMV], reovirus-3 [Reo-3]); CPE with no or variable replication (Ross River virus [RRV], fowl plague virus [FPV], Cache Valley virus [CVV], vesicular stomatitis virus [VSV]); no CPE but replication (parainfluenza virus 3 [PIV-3]); and no CPE and no replication (bovine viral diarrhea virus [BVDV], coxsackievirus B3 [CVB3], murine hepatitis virus [MHV], pseudorabies virus [PRV], porcine parvovirus [PPV]).
- hAdV was difficult to interpret: CPE was subtle, infectious virus remained stable at a mean of 3.0–3.6 log10 TCID50, and the hold control showed 4.3 log10 TCID50 after 14 days at 36 ± 2°C versus an input of 5.2 log10 TCID50, suggesting residual input virus. EMCV, MMV, and Reo-3 were reliably detected by CPE on CHO cells.
- CVV and VSV replicated variably; CVV showed <0.9 and 5.4 log10 TCID50 in replicates, and VSV reached a mean of 4.5 log10 TCID50 at day 14. PIV-3 did not induce CPE but replicated moderately, with a hold control <0.1 log10 TCID50.
- During AAT, supernatants from hAdV- or PIV-3-inoculated CHO cells produced clear CPE on MRC-5, Vero, and 324K cells but not CHO cells; hAdV was also detected by hemagglutination, and PIV-3 by hemadsorption and hemagglutination. The authors conclude current AAT is effective for viruses that can replicate in CHO cells.
Methods
- CHO cells were inoculated with 14 viruses at MOI = 1 (except FPV, for which approximately 10^4 particles/well were used) for 1 h, washed, incubated for 7 ± 1 days, then supernatant was transferred to fresh CHO cells for a second 7 ± 1 days. Each setup was done in duplicate and repeated at least once.
- Infectivity was titrated by TCID50 on virus-specific susceptible cell lines from the input inoculum, second wash, 7-day and 14-day CHO supernatants, and hold controls for selected enveloped and non-enveloped viruses incubated at 36 ± 2°C for 14 days.
- AAT used 14-day CHO culture supernatant added to MRC-5, Vero, CHO, and 324K cells, incubated for 14 days (MRC-5, Vero, CHO) or 21 days (324K), then assessed for CPE, hemadsorption, and hemagglutination with erythrocyte suspensions.
Limitations
- The paper states that hAdV results were difficult to interpret and that the proposed explanation for FPV’s behavior remains speculative and would require further studies.
- The paper notes that no systematic investigation of CHO virus susceptibility had previously been published, and it did not include porcine circovirus because prior experiments showed no productive replication in CHO cells.
- Evident from the text: the screen covers only 14 viruses from 12 families and is an in vitro study; it does not test all possible adventitious agents, and Vesivirus 2117 was not included in the panel despite being discussed as a prior contamination concern.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 25 cited sources checked · 0 supported · 0 flagged
- Findingown data
The infectivity detected on the susceptible cell line after the first and second 7 ± 1 days incubation was not due to residual virus inoculum.
“The infectivity detected on the susceptible cell line after the first and second 7 Æ 1 days incubation was not due to residual virus inoculum, as the virus was completely inactivated after 14 days at 36 Æ 28C (viral load of the hold control <0.1 log 10 [TCID 50 ]).”
Quote in the paperSubstantial claim - Findingown data
For CVV, virus loads of <0.9 and 5.4 log10 TCID50 were detected for replicates of the same virus.
“which resulted, for example, in the detection of virus loads of <0.9 and 5.4 log 10 [TCID 50 ] for replicates of the same virus (CVV, Fig. 2B, Supplementary Table I).”
Quote in the paperNot a substantial claim - Findingown data
PIV-3 presence was shown by HA with positive results using MRC-5, Vero and 324K cell culture supernatants.
“In addition, the presence of PIV-3 was clearly shown with HAD (positive result on CHO, MRC-5 and Vero cells) and with HA (positive result by using MRC-5, Vero and 324K cell culture supernatants) assays (Table III).”
Quote in the paperSubstantial claim - Findingown data
RRV, FPV, CVV, and VSV rapidly induced a CPE in CHO cells.
“In summary, the results obtained for RRV, FPV, CVV, and VSV showed that these viruses rapidly induced a CPE in CHO cells and any contamination of the CHO cell fermenter would therefore be detected.”
Quote in the paperSubstantial claim - Findingown data
BVDV, CVB3, MHV, PRV and PPV did not induce a CPE in CHO cell culture.
“Bovine viral diarrhea virus (BVDV), Coxsackievirus B3 (CVB3), Murine hepatitis virus (MHV), Pseudorabies virus (PRV) and Porcine parvovirus (PPV) did not induce a CPE in CHO cell culture (Fig. 2D, Supplementary Table I).”
Quote in the paperSubstantial claim
- Findingown data
For CVV and VSV, higher titers were detected more consistently in the 14-day CHO cell culture supernatant than after the first 7 ± 1 days incubation.
“In the case of CVV and more so VSV, the ability to reproduce on CHO cells appeared to improve after the first 7 Æ 1 days incubation, possibly indicating an adaption of the virus to growth in CHO cells, as higher titers were detected more consistently in the 14d CHO cell culture supernatant (Fig. 2B, Supplementary Table I).”
Quote in the paperSubstantial claim - Findingown data
PIV-3 presence was shown by HAD with positive results on CHO, MRC-5 and Vero cells.
“In addition, the presence of PIV-3 was clearly shown with HAD (positive result on CHO, MRC-5 and Vero cells) and with HA (positive result by using MRC-5, Vero and 324K cell culture supernatants) assays (Table III).”
Quote in the paperSubstantial claim - Findingown data
Human adenovirus, encephalomyocarditis virus, Mice minute virus, and Reovirus-3 induced a cytopathic effect in CHO cell culture after 7 ± 1 days of incubation.
“After 7 Æ 1 days of CHO cell incubation with virus, Human Adenovirus (hAdV), Encephalomyocarditis virus (EMCV), Mice minute virus (MMV) and Reovirus-3 (Reo-3) induced a CPE in CHO cell culture (Fig. 2A, Supplementary Table I).”
Quote in the paperSubstantial claim - Findingown data
PIV-3 was the only virus in the study that did not induce a CPE in CHO cell culture.
“In this study, PIV-3 was the only virus that did not induce a CPE, yet was able to replicate moderately in CHO cell culture (Fig. 2C, Supplementary Table I).”
Quote in the paperSubstantial claim - Findingown data
For PRV and PPV, some residual infectivity was detected after the first 7 ± 1 days incubation (mean of four replicates: 1.3 and 2.0 log10 [TCID50], respectively).
“In the case of PRV and PPV, some residual infectivity was detected after the first 7 Æ 1 days incubation (mean of four replicates: 1.3 and 2.0 log 10 [TCID 50 ], respectively), which was reduced to no detectable infectivity after the second 7 Æ 1 days incubation for PRV and to 1.1 log 10 [TCID 50 ] for PPV (Fig. 2D, Supplementary Table I).”
Quote in the paperSubstantial claim - Findingown data
EMCV, MMV, and Reo-3 were able to replicate in CHO cells, shown by high infectious virus concentrations after 7 ± 1 days and after re-inoculation and a second 7 ± 1 days.
“The results obtained from the TCID 50 assays indicated that these viruses were able to replicate in CHO cells, which was shown by the high infectious virus concentrations obtained after the 7 Æ 1 days incubation, as well as after the re-inoculation and second 7 Æ 1 days incubation (Fig. 2A, Supplementary Table I).”
Quote in the paperSubstantial claim - Findingown data
The presence of EMCV, MMV, and Reo-3 can be reliably detected through the induction of a cytopathic effect on CHO cells.
“Overall, the results obtained for these viruses clearly show that the presence of EMCV, MMV and Reo-3 can be reliably detected through the induction of a CPE on CHO cells”
Quote in the paperSubstantial claim - Findingown data
None of BVDV, CVB3, MHV, PRV and PPV were able to infect CHO cells.
“In summary, none of these viruses were able to infect CHO cells and a potential infection of the cell line would therefore not result in virus replication.”
Quote in the paperSubstantial claim - Findingown data
No infectious virus was detected throughout the experiment for BVDV, CVB3, and MHV.
“No infectious virus was detected throughout the experiment for BVDV, CVB3, and MHV.”
Quote in the paperSubstantial claim - Findingown data
Four different infection outcomes can be distinguished based on combinations of induction of a cytopathic effect and ability to replicate in CHO cells.
“Based on our results, four different infection outcomes were distinguished, based on the possible combinations of the two factors (i) the induction, or not, of a cytopathic effect and (ii) the ability, or not, to replicate in CHO cells.”
- Also stated in: § Results and Discussion · plain
“The results obtained from the inoculation and incubation of CHO cells with a panel of viruses showed that four different infection outcomes can be distinguished.”
Quote in the paperSubstantial claim - Also stated in: § Results and Discussion · plain
- Findingown data
PIV-3 was able to replicate moderately in CHO cell culture.
“In this study, PIV-3 was the only virus that did not induce a CPE, yet was able to replicate moderately in CHO cell culture (Fig. 2C, Supplementary Table I).”
Quote in the paperSubstantial claim - Findingown data
Ross River virus, Fowl plague virus, Cache Valley virus, and Vesicular stomatitis virus rapidly induced a cytopathic effect on CHO cells, apparent latest after 6 days of incubation.
“Ross River virus (RRV), Fowl plague virus (FPV), Cache Valley virus (CVV) and Vesicular stomatitis virus (VSV) rapidly induced a CPE on CHO cells, which became apparent the latest after 6 days of incubation.”
Quote in the paperSubstantial claim - Interpretationreasoning
Any contamination of the CHO cell fermenter with RRV, FPV, CVV, or VSV would be detected.
“In summary, the results obtained for RRV, FPV, CVV, and VSV showed that these viruses rapidly induced a CPE in CHO cells and any contamination of the CHO cell fermenter would therefore be detected.”
Quote in the paperSubstantial claim- Rests on an assumption: A cytopathic effect observed in CHO cell culture would be detected in a CHO cell fermenter.
- Premisecitation
Previously published experiments showed no productive replication of Porcine circovirus in CHO cells.
“Although experimental infection of CHO cells with Porcine circovirus, a member of the Circoviridae, has been shown (Misinzo et al., 2006), this virus was not included in the present screen, as the previously published experiments showed no productive replication in CHO cells and no substantial safety concerns are therefore expected from this virus.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Misinzo et al., 2006 source
- Premisecitation
The contaminating viruses in CHO cell-derived bulk harvests were identified as Mice minute virus, Reovirus, Cache Valley virus, Epizootic hemorrhagic disease virus, and Vesivirus 2117.
“The contaminating viruses were identified as Mice minute virus (Garnick, 1996;Nims, 2006), Reovirus (Nims, 2006), Cache Valley virus (Nims, 2006), Epizootic hemorrhagic disease virus (Rabenau et al., 1993) and most recently, Vesivirus 2117 (Genzyme, 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Garnick, 1996
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Nims, 2006
- cites Genzyme, 2009
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
A clearly visible CPE on CHO cells had previously been described for Vesivirus 2117.
“For Vesivirus 2117, a member of the Caliciviridae and the virus that was implicated in the most recent widely visible cell culture contamination (Genzyme, 2009), a clearly visible CPE on CHO cells had previously been described (Oehmig, et al., 2003) and the virus is therefore detectable during manufacture and AAT.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Oehmig, et al., 2003 source
- Interpretationown data
The lack of a cytopathic effect on CHO cells during AAT indicates that hAdV is not able to reproduce on CHO cells efficiently.
“This lack of a CPE on CHO cells during AAT is a further indication that hAdV is not able to reproduce on CHO cells efficiently, an observation that has been reported previously (Condon et al., 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Condon et al., 2003 source
- Interpretationcitation
Contamination of CHO cells by adenoviruses cannot be ruled out.
“and contamination of CHO cells by these viruses cannot be ruled out.”
Quote in the paperSubstantial claim - Premisecitation
An Adenovirus-permissive CHO cell clone has been described.
“Nevertheless, an Adenovirus-permissive CHO cell clone has been described (Condon et al., 2003)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Condon et al., 2003 source
- Premisecitation
In all reported cases of CHO cell-derived bulk harvest contamination, raw materials used in production were suspected as the source of viral contamination.
“In all of these reported cases, raw materials used in production were suspected as the source of viral contamination (Garnick, 1998;Rabenau et al., 1993;Onions, 2004).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Garnick, 1998
- cites Rabenau et al., 1993 source
- cites Onions, 2004
- Premisecitation
Only a few documented historical contaminations of CHO cells have occurred.
“For CHO cells, despite their wide use in various biotechnology applications, only a few documented historical contaminations have occurred (Garnick, 1996;Nims, 2006;Rabenau et al., 1993), which strengthens the argument of inherently high safety margins associated with the use of this cell line.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Garnick, 1996
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Nims, 2006
- cites Rabenau et al., 1993 source
- Interpretationcitation
No substantial safety concerns are expected from Porcine circovirus.
“Although experimental infection of CHO cells with Porcine circovirus, a member of the Circoviridae, has been shown (Misinzo et al., 2006), this virus was not included in the present screen, as the previously published experiments showed no productive replication in CHO cells and no substantial safety concerns are therefore expected from this virus.”
Quote in the paperSubstantial claim - Interpretationown data
Parainfluenza virus contamination of a manufacturing process would be detected by AAT.
“Overall, the results indicate that Parainfluenza virus contamination of a manufacturing process would be detected by AAT and the effectiveness of the current AAT system to detect an example of a virus that can replicate in CHO cells without an apparent CPE was confirmed.”
Quote in the paperSubstantial claim - Interpretationown data
The current AAT system is effective to detect a virus that can replicate in CHO cells without an apparent CPE.
“Overall, the results indicate that Parainfluenza virus contamination of a manufacturing process would be detected by AAT and the effectiveness of the current AAT system to detect an example of a virus that can replicate in CHO cells without an apparent CPE was confirmed.”
Quote in the paperSubstantial claim- Rests on an assumption: PIV-3 is representative of viruses that can replicate in CHO cells without an apparent CPE.
- Interpretationown data
The remaining infectivity of PRV and PPV was most likely due to the robustness of the viruses.
“This remaining infectivity was most likely due to the robustness of the viruses, as, for example, the viral load of the PPV hold control was 2.2 log 10 [TCID 50 ] after 14 days at 36 Æ 28C, compared to a virus input of 5.0 log 10 [TCID 50 ].”
Quote in the paperNot a substantial claim - Interpretationown data
A potential infection of CHO cells with BVDV, CVB3, MHV, PRV or PPV would not result in virus replication.
“In summary, none of these viruses were able to infect CHO cells and a potential infection of the cell line would therefore not result in virus replication.”
Quote in the paperSubstantial claim - Interpretationcitation
The few documented historical contaminations of CHO cells strengthen the argument of inherently high safety margins associated with the use of this cell line.
“For CHO cells, despite their wide use in various biotechnology applications, only a few documented historical contaminations have occurred (Garnick, 1996;Nims, 2006;Rabenau et al., 1993), which strengthens the argument of inherently high safety margins associated with the use of this cell line.”
Quote in the paperSubstantial claim - Premisecitation
Previous CHO cell infections with PIV-3 and other members of the Paramyxoviridae (e.g., Simian virus 5, Mumps virus and Bovine respiratory syncytial virus) had been reported.
“Parainfluenza Virus 3 (PIV-3) was included in the study as previous CHO cell infections with this virus, as well as with other members of the Paramyxoviridae (e.g., Simian virus 5, Mumps virus and Bovine respiratory syncytial virus) had been reported (Potts, 2008;Wisher, 2005).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Potts, 2008
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Wisher, 2005
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
The current AAT is effective for the detection of viruses that are able to replicate in CHO cells.
“Our results demonstrate that the current AAT is effective for the detection of viruses which are able to replicate in CHO cells.”
- Also stated in: § Introduction · boosted
“The results obtained from this systematic screen confirm the effectiveness of the current AAT system to detect viruses that can replicate in CHO cells.”
Quote in the paperSubstantial claim - Also stated in: § Introduction · boosted
- Interpretationown data
Infectivity detected after 14 days of hAdV incubation might be due to residual input virus.
“suggesting that infectivity detected after 14 days of incubation might be due to residual input virus.”
Quote in the paperSubstantial claim - Premisecitation
BHK cells are permissive for a broader range of viruses than CHO cells.
“Based on published studies and evidence reported at conferences, a comparison of the virus susceptibility of CHO and BHK cell lines indicated that BHK cells are permissive for a broader range of viruses than CHO cells (Table I).”
Quote in the paperNot a substantial claim - Interpretationreasoning
Due to the restricted virus susceptibility of CHO cells and routine AAT of bulk harvests, the results provide reassurance for the very high safety margins of CHO cell-derived biopharmaceuticals.
“Due to the restricted virus susceptibility of CHO cells and the routine AAT of bulk harvests, our results provide re-assurance for the very high safety margins of CHO cell-derived biopharmaceuticals.”
Quote in the paperSubstantial claim - Premisecitation
Regulatory guidance requires adventitious agent testing (AAT) of the bulk harvest to ensure the safety of biological therapeutics.
“To ensure the safety of biological therapeutics, regulatory guidance requires adventitious agent testing (AAT) of the bulk harvest.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites FDA, 1998
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
A contamination with hAdV is clearly shown during routine AAT.
“whereas a contamination with hAdV is clearly shown during routine AAT.”
Quote in the paperSubstantial claim - Interpretationown data
The combination of restricted virus susceptibility of CHO cells and an effective routine AAT of bulk harvests provides high safety margins for CHO-cell derived biopharmaceuticals.
“Our systematic screen gives evidence for the restricted virus susceptibility of CHO cells (as compared to, e.g., BHK cells), which, in combination with an effective routine AAT of bulk harvests, provides high safety margins for CHO-cell derived biopharmaceuticals.”
Quote in the paperSubstantial claim- Rests on an assumption: The panel of viruses tested is representative of viruses that could contaminate CHO cell manufacturing processes.
- Interpretationown data
CHO cells have restricted virus susceptibility compared to BHK cells.
“Our systematic screen gives evidence for the restricted virus susceptibility of CHO cells (as compared to, e.g., BHK cells), which, in combination with an effective routine AAT of bulk harvests, provides high safety margins for CHO-cell derived biopharmaceuticals.”
Quote in the paperSubstantial claim- Rests on an assumption: The panel of viruses tested is representative of viruses that could contaminate CHO cell manufacturing processes.
- Interpretationown data
The current AAT system is effective for the detection of viruses that can replicate in CHO cells.
“In conclusion, our results demonstrate that viral infections of CHO cells are detectable, either through the induction of a clearly visible CPE, or during routine AAT and we provide evidence that the current AAT system is effective for the detection of viruses that can replicate in CHO cells.”
Quote in the paperSubstantial claim- Rests on an assumption: PIV-3 is representative of viruses that can replicate in CHO cells without an apparent CPE.
- May combine two claims. 17
- Classified as probably not a substantial claim. 8
- The quote only partly states this claim. 1
May combine two claims.
Findingown dataThe cytopathic effect associated with hAdV infection of CHO cells was difficult to assess, with subtle cell changes and no extensive cell layer destruction.
“However, the CPE associated with hAdV infection of CHO cells was difficult to assess, as the observed cell changes were subtle and no extensive cell layer destruction occurred.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe presence of hAdV was clearly shown by hemagglutination, with a positive result obtained with the supernatant of MRC-5 cells.
“In addition to the detection of hAdV through the induction of a CPE on various cell lines during AAT, the presence of hAdV was clearly shown by HA, as a positive result was obtained with the supernatant of MRC-5 cells (Table III).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataRRV, FPV, CVV, and VSV were rather thermosensitive; no infectivity was detected in the hold controls after 14 days at 36 ± 2°C.
“These viruses were all rather thermosensitive, as no infectivity was detected in the hold controls after 14 days of incubation at 36 Æ 28C (Fig. 2B, Supplementary Table I).”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningFor FPV, a clear cytopathic effect was observed during the first few days of incubation, yet infectious virus was not detected on the susceptible cell line throughout the experiment.
“For the Influenza A virus FPV a clear CPE was already observed during the first few days of incubation, yet infectious virus was not detected on the susceptible cell line throughout the course of the experiment.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAfter the second 7 ± 1 days incubation, PRV infectivity was reduced to no detectable infectivity and PPV infectivity was reduced to 1.1 log10 [TCID50].
“In the case of PRV and PPV, some residual infectivity was detected after the first 7 Æ 1 days incubation (mean of four replicates: 1.3 and 2.0 log 10 [TCID 50 ], respectively), which was reduced to no detectable infectivity after the second 7 Æ 1 days incubation for PRV and to 1.1 log 10 [TCID 50 ] for PPV (Fig. 2D, Supplementary Table I).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDuring AAT, supernatant from CHO cells inoculated and incubated with PIV-3 for 14 days induced a clear CPE on MRC-5, Vero, and 324K cells after 14 days of incubation, but not on CHO cells.
“A clear CPE was observed on these cell lines after 14 days of incubation, with the exception of CHO cells (Table III).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFor RRV, FPV, CVV, and VSV, no or variable virus replication was observed, with no or very little infectious virus after the first 7 ± 1 days and variable replication during the second 7 ± 1 days.
“However, no or rather variable virus replication was observed, characterized by the presence of no or very little infectious virus after the first 7 Æ 1 days of CHO cell incubation and a subsequent variable replication during the second 7 Æ 1 days of incubation”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datahAdV did not show clear replication in CHO cells; its infectious virus load did not increase significantly between the second wash and the supernatant after 7 and 14 days, remaining stable at a mean of 3.0-3.6 log10 TCID50.
“Similar to the CPE results obtained for hAdV, no clear replication was observed for this virus: the load of infectious virus particles did not increase significantly between the second wash and the supernatant after 7 and 14 days of incubation but remained stable at a mean of 3.0-3.6log 10 [TCID 50 ] throughout the experiment (Fig. 2A, Supplementary Table I).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBVDV, CVB3, MHV, PRV and PPV were not able to replicate in CHO cells.
“The results obtained from the TCID 50 assays indicated that these viruses were not able to replicate in CHO cells.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDuring AAT with hAdV-infected CHO supernatant, clear cytopathic effect was observed on MRC-5, Vero, and 324K cells after 14 days, but not on CHO cells.
“A clear CPE was observed on these cell lines after 14 days of incubation, with the exception of CHO cells (Table III).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTCID50 titrations of CVV showed small amounts of infectious virus once out of six determinations (1.2 log10 TCID50) after 7 ± 1 days, and twice out of six after re-inoculation and the second 7 ± 1 days (4.2 and 5.4 log10 TCID50).
“TCID 50 titrations of CVV showed the presence of small amounts of infectious virus once (out of six determinations, 1.2 log 10 [TCID 50 ]) after 7 Æ 1 days of virus incubation on CHO cells and twice (out of six determinations) after re-inoculation and the second 7 Æ 1 days incubation (4.2 and 5.4 log 10 [TCID 50 ]; day 14; Fig. 2B, Supplementary Table I).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datahAdV is robust; its hold control load was 4.3 log10 TCID50 after 14 days at 36 ± 2°C compared to an input of 5.2 log10 TCID50.
“The hAdV hold control showed that this virus is robust (load of 4.3 log 10 [TCID 50 ] after 14 days at 36 Æ 28C, compared to an input of 5.2 log 10 [TCID 50 ])”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenFor each virus, the CHO cell inoculation and incubation setup was done in duplicate and repeated at least once.
“For each virus, this setup was done in duplicate and repeated at least once.”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
Interpretationown dataThe rapidly induced cytopathic effect on CHO cells indicated that RRV, FPV, CVV, and VSV were initially able to infect and destroy CHO cells, yet no or few replication-competent progeny viruses were released into the supernatant.
“The rapidly induced CPE on CHO cells indicated that all of these viruses were initially able to infect and destroy CHO cells, yet no or few replication-competent progeny viruses were released into the supernatant.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationViral contaminations of CHO cell-derived bulk harvests are rare but have occurred.
“Viral contaminations of CHO cell-derived bulk harvests are rare, but have occurred.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Garnick, 1996
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Nims, 2006
- cites Genzyme, 2009
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenAAT procedures involve a broad virus screen on a variety of cell lines, in which cytopathic effect, hemadsorption, and hemagglutination are assayed.
“AAT procedures have been developed in a deliberately promiscuous fashion to indicate the presence of, ideally, any viral contaminant and involve a broad virus screen on a variety of cell lines, in which cytopathic effect (CPE), hemadsorption (HAD) and hemagglutination (HA) are assayed.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationExperimental infection of CHO cells with Porcine circovirus has been shown.
“Although experimental infection of CHO cells with Porcine circovirus, a member of the Circoviridae, has been shown (Misinzo et al., 2006), this virus was not included in the present screen, as the previously published experiments showed no productive replication in CHO cells and no substantial safety concerns are therefore expected from this virus.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Misinzo et al., 2006 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA literature survey suggests that CHO cells are less permissive to infection by viruses than other cell lines used in the production of recombinant proteins, such as BHK cells.
“In addition, a literature survey might suggest that CHO cells are less permissive to infection by viruses than other cell lines used in the production of recombinant proteins, such as baby hamster kidney (BHK) cells (Table I).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table I
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim.
Premisenone givenAAT is a deliberately promiscuous assay procedure developed to indicate, ideally, the presence of any viral contaminant.
“AAT is a deliberately promiscuous assay procedure which has been developed to indicate, ideally, the presence of any viral contaminant.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCHO cells are one of the main cell lines used in the production of recombinant therapeutics.
“Chinese hamster ovary (CHO) cells are one of the main cell lines used in the production of recombinant therapeutics (Wurm, 2004; see Grillberger et al., 2009 for examples of proteins produced in CHO cells).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wurm, 2004 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA specific assay for Mice minute virus is included in AAT as recommended for monoclonal antibody and vaccine production.
“In addition, a more specific assay for Mice minute virus is included, as recommended for monoclonal antibody and vaccine production (FDA, 1997;FDA, 2006), in which, for example, CPE and HA are assayed on a susceptible cell line.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites FDA, 1997
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites FDA, 2006
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationA remaining risk of cell culture contamination events still exists.
“However, this recent contamination of a manufacturing facility painfully underlines that a remaining risk of such events still exists.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Genzyme, 2009
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationown dataViral infections of CHO cells are detectable either through the induction of a clearly visible CPE or during routine AAT.
“In conclusion, our results demonstrate that viral infections of CHO cells are detectable, either through the induction of a clearly visible CPE, or during routine AAT and we provide evidence that the current AAT system is effective for the detection of viruses that can replicate in CHO cells.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationVesivirus 2117 is detectable during manufacture and AAT.
“For Vesivirus 2117, a member of the Caliciviridae and the virus that was implicated in the most recent widely visible cell culture contamination (Genzyme, 2009), a clearly visible CPE on CHO cells had previously been described (Oehmig, et al., 2003) and the virus is therefore detectable during manufacture and AAT.”
Quote in the paperSubstantial claim
The paper relies on this without support.
No systematic investigation of CHO cell virus susceptibility had been published.
“a systematic screen of their virus susceptibility has never been published.”
“no systematic investigation of their virus susceptibility has to date been published.”
The paper relies on this without support.
The described AAT is the routine procedure used for the assessment of recombinant protein bulk harvests from CHO cells.
“The described AAT is the routine procedure used for the assessment of recombinant protein bulk harvests from CHO cells.”
The paper relies on this without support.
The panel of viruses tested is representative of viruses that could contaminate CHO cell manufacturing processes.
“included representatives or the very species of viruses that were involved in previously reported infections”
The paper relies on this without support.
A cytopathic effect observed in CHO cell culture would be detected in a CHO cell fermenter.
“any contamination of the CHO cell fermenter would therefore be detected.”
The paper relies on this without support.
PIV-3 is representative of viruses that can replicate in CHO cells without an apparent CPE.
“the effectiveness of the current AAT system to detect an example of a virus that can replicate in CHO cells without an apparent CPE was confirmed.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Circovirus type in Table I differs from the cited reference
MinorTable I lists the cited study under porcine circovirus 1, but the reference title identifies its subject as porcine circovirus 2.
“Porcine circovirus 1 Misinzo et al. (2006)”
“Misinzo G, Delputte PL, Meerts P, Lefebvre DJ, Nauwynck HJ. 2006. Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells.”
Cites
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032 · cited 4× · see citing works
“Chinese hamster ovary (CHO) cells are one of the main cell lines used in the production of recombinant therapeutics (Wurm, 2004; see Grillberger et al., 2009 for examples of proteins produced in CHO cells).”
BackgroundInfluentialBiopharmaceutical benchmarks 2006
Walsh, G. (2006) · Nature Biotechnology · doi:10.1038/nbt0706-769 · Cited by 359 · cited 1× · see citing works
“…1980s, the first recombinant medicinal products from mammalian cell cultures have become available (for review see Grillberger et al., 2009) and since then, production of therapeutics in cell lines has become prevalent, with more than 165 biopharmaceuticals now approved world-wide (Walsh, 2006).”
BackgroundSu, H., Liao, C., & Lin, Y. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4162-4171.2002 · Cited by 340 · cited 1× · see citing works
“…et al. (2008), Marsh and Bron (1997) Sindbis virus Potts (2008) Gorchakov et al. (2008), Sanz et al. (2007) Rubella virus — Malathi et al. (2001) Japanese encephalitis virus — Tsai et al. (2007), Su et al. (2002) Eastern equine encephalitis virus — Petrakova et al. (2005) Venezuelan equine…”
Background&NA;, &. (1997) · Journal of Immunotherapy · doi:10.1097/00002371-199705000-00007 · Cited by 232 · see citing works
Influenza virus entry and infection require host cell N-linked glycoprotein
Chu, V. C., & Whittaker, G. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405172102 · Cited by 208 · cited 1× · see citing works
“(2007) , Chu and Whittaker (2004) Govorkova et al.”
BackgroundHe, B., Paterson, R. G., Stock, N., Durbin, J. E., Durbin, R. K., Goodbourn, S., Randall, R. E., & Lamb, R. A. (2002) · Virology · doi:10.1006/viro.2002.1738 · Cited by 183 · cited 5× · see citing works
“…(2007) Paramyxoviridae Parainfluenza virus 1/2/3 Potts (2008) Nishio et al. (2005), Shimokata et al. (1981), De et al. (1991) Simian virus 5 Potts (2008) He et al. (2002) Mumps virus Wisher (2005), Potts (2008) McCammon and Riesser (1979) Bovine respiratory syncytial virus Potts (2008) — Sendai…”
BackgroundInfluentialMisinzo, G., Delputte, P. L., Meerts, P., Lefebvre, D. J., & Nauwynck, H. J. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3487-3494.2006 · Cited by 170 · cited 5× · see citing works
“Although experimental infection of CHO cells with Porcine circovirus, a member of the Circoviridae, has been shown (Misinzo et al., 2006) , this virus was not included in the present screen, as the previously published experiments showed no productive replication in CHO cells and no substantial safety concerns are the…”
BackgroundResultInfluentialReceptor binding specificity of recent human H3N2 influenza viruses
Kumari, K., Gulati, S., Smith, D. F., Gulati, U., Cummings, R. D., & Air, G. M. (2007) · Virology Journal · doi:10.1186/1743-422x-4-42 · Cited by 164 · see citing works
Petrakova, O., Volkova, E., Gorchakov, R., Paessler, S., Kinney, R., & Frolov, I. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7597-7608.2005 · Cited by 148 · cited 2× · see citing works
“…Potts (2008) Gorchakov et al. (2008), Sanz et al. (2007) Rubella virus — Malathi et al. (2001) Japanese encephalitis virus — Tsai et al. (2007), Su et al. (2002) Eastern equine encephalitis virus — Petrakova et al. (2005) Venezuelan equine encephalitis virus — Petrakova et al.…”
BackgroundGrillberger, L., Kreil, T. R., Nasr, S., & Reiter, M. (2009) · Biotechnology Journal · doi:10.1002/biot.200800241 · Cited by 144 · cited 2× · see citing works
“Chinese hamster ovary (CHO) cells are one of the main cell lines used in the production of recombinant therapeutics (Wurm, 2004; see Grillberger et al., 2009 for examples of proteins produced in CHO cells).”
BackgroundSelf-citationLiberato, C. D., Scavia, G., Lorenzetti, R., et al. (2005) · Veterinary Record · doi:10.1136/vr.156.10.301 · Cited by 126 · see citing works
Patkar, C. G., & Kuhn, R. J. (2008) · Journal of Virology · doi:10.1128/jvi.02447-07 · Cited by 120 · see citing works
Polymorphism and Structural Maturation of Bunyamwera Virus in Golgi and Post-Golgi Compartments
Salanueva, Í. J., Novoa, R. R., Cabezas, P., et al. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1368-1381.2003 · Cited by 117 · cited 6× · see citing works
“(2006) — Theiler’s mouse encephalitis virus — Son et al. (2008), Takano-Maruyama et al. (2006) Foot and mouth disease virus — Vagnozzi et al. (2007), Carrillo et al.”
BackgroundInfluentialMarsh, M., & Bron, R. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.1.95 · Cited by 109 · see citing works
Role of CD151, A tetraspanin, in porcine reproductive and respiratory syndrome virus infection
Shanmukhappa, K. S., Kim, J.-K., & Kapil, S. (2007) · Virology Journal · doi:10.1186/1743-422x-4-62 · Cited by 103 · cited 2× · see citing works
“…al. (2002) Eastern equine encephalitis virus — Petrakova et al. (2005) Venezuelan equine encephalitis virus — Petrakova et al. (2005) Arteriviridae Porcine reproductive and respiratory syndrome virus — Shanmukhappa et al. (2007) Retroviridae Foamy virus — Li et al. (2002) ds RNA Reoviridae…”
BackgroundNg, C. S. H., GU, F., Phong, W. Y., et al. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2007.06.007 · Cited by 100 · cited 1× · see citing works
“…Bovine coronavirus Francis (2003) — Murine hepatitis virus — Matsuyama and Taguchi (2000) Flaviviridae Yellow fever virus — Patkar and Kuhn (2008) Dengue virus — Ng et al. (2007) West Nile virus — Widman et al. (2008), Puig-Basagoiti et al. (2007) Tick borne encephalitis virus — Goto…”
Background(1996) · PubMed · Cited by 95 · see citing works
Longo, F. J., Lynn, J. W., McCulloh, D. H., et al. (1986) · Developmental Biology · doi:10.1016/0012-1606(86)90083-7 · Cited by 94 · see citing works
Nájera, J. L., Gómez, C. E., Domingo-Gil, E., et al. (2006) · Journal of Virology · doi:10.1128/jvi.02108-05 · Cited by 83 · cited 1× · see citing works
“…(1985), Nettleton and Rweyemamu (1980) Circoviridae Porcine circovirus 1 Misinzo et al. (2006) — ds DNA Adenoviridae Adenovirus Condon et al. (2003) Hosel et al. (2003) Poxviridae Modified vaccinia virus ‘Ankara’ — Najera et al. (2006) Herpesviridae Pseudorabies virus Nixdorf et al. (1999) Slivac…”
BackgroundKnowles, N. J., Buckley, L. S., & Pereira, H. G. (1979) · Archives of Virology · doi:10.1007/bf01317552 · Cited by 83 · cited 1× · see citing works
“…et al. (2006) Foot and mouth disease virus — Vagnozzi et al. (2007), Carrillo et al. (2007), Garcia-Briones et al. (2006) Bovine enterovirus — Smyth et al. (2002) Porcine enterovirus — Knowles et al. (1979) Togaviridae Semliki Forest virus Marsh and Bron (1997) Kiiver et al. (2008), Marsh…”
BackgroundA New Role for ns Polyprotein Cleavage in Sindbis Virus Replication
Gorchakov, R. V., Frolova, E. I., Sawicki, S. G., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02624-07 · Cited by 80 · cited 3× · see citing works
“Marsh M, Bron R. 1997.”
BackgroundInduction of apoptosis in frog virus 3-infected cells
Chinchar, V. G., Bryan, L. J., Wang, J., et al. (2003) · Virology · doi:10.1016/s0042-6822(02)00039-9 · Cited by 79 · cited 1× · see citing works
“…— Najera et al. (2006) Herpesviridae Pseudorabies virus Nixdorf et al. (1999) Slivac et al. (2006) Murine gammaherpes 68 — Gillet et al. (2006) Herpes simplex virus 1 — Conner et al. (2005) Iridoviridae Frog virus 3 — Chinchar et al. (2003) Berting et al.: Virus Susceptibility of CHO Cells…”
BackgroundCarrillo, C., Lu, Z., Borca, M. V., Vagnozzi, A. E., Kutish, G. F., & Rock, D. L. (2007) · Journal of Virology · doi:10.1128/jvi.00930-07 · Cited by 77 · cited 10× · see citing works
“(2007), Carrillo et al. (2007), Garcia-Briones et al. (2006) Bovine enterovirus — Smyth et al. (2002) Porcine enterovirus — Knowles et al. (1979) Togaviridae Semliki Forest virus Marsh and Bron (1997) Kiiver et al. (2008), Marsh and Bron (1997) Sindbis virus Potts (2008) Gorchakov et al. (2008), Sanz et al. (2007) Rub…”
BackgroundInfluentialNishio, M., Tsurudome, M., Ito, M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8591-8601.2005 · Cited by 75 · cited 5× · see citing works
“We thank Barbara Potts for raising our interest in the subject and for initial discussions.”
BackgroundInfluential(1998) · PubMed · Cited by 73 · see citing works
Contamination of Genetically Engineered CHO-cells by Epizootic Haemorrhagic Disease Virus (EHDV)
Rabenau, H., Ohlinger, V., Anderson, J., Selb, B., Cinatl, J., Wolf, W., Frost, J., Mellor, P., & Doerr, H. W. (1993) · Biologicals · doi:10.1006/biol.1993.1077 · Cited by 68 · cited 14× · see citing works
“In the case of CVV and more so VSV, the ability to reproduce on CHO cells appeared to improve after the first 7 1 days incubation, possibly indicating an adaption of the virus to growth in CHO cells, as higher titers were detected more consistently in the 14d CHO cell culture supernatant (Fig.”
BackgroundMethodInfluentialHuman parainfluenza virus type 3 transcription in vitro: role of cellular actin in mRNA synthesis
De, B. P., Lesoon, A., & Ak, B. (1991) · Journal of Virology · doi:10.1128/jvi.65.6.3268-3275.1991 · Cited by 67 · cited 3× · see citing works
“(1981), De et al. (1991) Simian virus 5 Potts (2008) He et al.”
BackgroundWidman, D. G., Ishikawa, T., Fayzulin, R. Z., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.009 · Cited by 62 · cited 1× · see citing works
“…(2003) — Murine hepatitis virus — Matsuyama and Taguchi (2000) Flaviviridae Yellow fever virus — Patkar and Kuhn (2008) Dengue virus — Ng et al. (2007) West Nile virus — Widman et al. (2008), Puig-Basagoiti et al. (2007) Tick borne encephalitis virus — Goto et al. (2003) St. Louis…”
BackgroundGoto, A., Hayasaka, D., Yoshii, K., et al. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00269-x · Cited by 62 · cited 2× · see citing works
“…Yellow fever virus — Patkar and Kuhn (2008) Dengue virus — Ng et al. (2007) West Nile virus — Widman et al. (2008), Puig-Basagoiti et al. (2007) Tick borne encephalitis virus — Goto et al. (2003) St. Louis encephalitis virus — McLean et al. (1978) Caliciviridae Vesivirus 2117 Oehmig et al.…”
BackgroundA mouse cell-adapted NS4B mutation attenuates West Nile virus RNA synthesis
Puig‐Basagoiti, F., Tilgner, M., Bennett, C. J., et al. (2006) · Virology · doi:10.1016/j.virol.2006.11.012 · Cited by 60 · cited 4× · see citing works
“Bunyamwera virus — Salanueva et al. (2003) Northway encephalitis virus — McLean et al.”
BackgroundInfluentialZautner, A. E., Jahn, B., Hammerschmidt, E., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01988-05 · Cited by 59 · cited 1× · see citing works
“…McLean et al. (1978) Caliciviridae Vesivirus 2117 Oehmig et al. (2003), Genzyme (2009) — Picornaviridae Encephalomyocarditis virus Potts (2008) Jia et al. (2008) Coxsackie virus B-3 Zautner et al. (2006) — Theiler’s mouse encephalitis virus — Son et al. (2008), Takano-Maruyama et al. (2006) Foot…”
BackgroundApoptosis induction by avian reovirus through p53 and mitochondria-mediated pathway
Chulu, J. L. C., Lee, L. H., Lee, Y. C., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.164 · Cited by 55 · cited 3× · see citing works
“…De et al. (2005) Epizootic hemorrhagic disease virus Rabenau et al. (1993) Aradaib et al. (1998) Reovirus 1/2/3 Nims (2006), Potts (2008) Gaillard and Joklik (1985) Avian reovirus — Chen et al. (2008), Chulu et al. (2007) Rotavirus — Lopez et al. (2006) ss DNA Parvoviridae Mice minute virus…”
Kallel, H., Jouini, A., Majoul, S., et al. (2002) · Journal of Biotechnology · doi:10.1016/s0168-1656(02)00009-3 · Cited by 54 · cited 1× · see citing works
“…— Slosaris et al. (1989) Pneumonia virus of mice — Weir et al. (1988) Rhabdoviridae Vesicular stomatitis virus Potts (2008) Connor et al. (2006) Rabies virus — Kallel et al. (2002) ss (þ) RNA Coronaviridae Bovine coronavirus Francis (2003) — Murine hepatitis virus — Matsuyama and Taguchi…”
BackgroundIdentification of a calicivirus isolate of unknown origin
Oehmig, A., Büttner, M., Weiland, F., Werz, W., Bergemann, K., & Pfaff, E. (2003) · Journal of General Virology · doi:10.1099/vir.0.19042-0 · Cited by 53 · cited 2× · see citing works
“…et al. (2008), Puig-Basagoiti et al. (2007) Tick borne encephalitis virus — Goto et al. (2003) St. Louis encephalitis virus — McLean et al. (1978) Caliciviridae Vesivirus 2117 Oehmig et al. (2003), Genzyme (2009) — Picornaviridae Encephalomyocarditis virus Potts (2008) Jia et al.…”
BackgroundGovorkova, E. A., Matrosovich, M. N., Tuzikov, A. B., et al. (1999) · Virology · doi:10.1006/viro.1999.9892 · Cited by 52 · cited 2× · see citing works
“(2007) , Chu and Whittaker (2004) Govorkova et al.”
BackgroundDifferential distribution of non-structural proteins of foot-and-mouth disease virus in BHK-21 cells
García-Briones, M., Rosas, M. F., González-Magaldi, M., et al. (2006) · Virology · doi:10.1016/j.virol.2006.02.042 · Cited by 52 · cited 4× · see citing works
“Carrillo C, Lu Z, Borca MV, Vagnozzi A, Kutish GF, Rock DL. 2007.”
BackgroundInfluential(2006) · PubMed · Cited by 50 · see citing works
Viral Translation Is Coupled to Transcription in Sindbis Virus-Infected Cells
Sanz, M. Á., Castelló, A., & Carrasco, L. (2007) · Journal of Virology · doi:10.1128/jvi.02529-06 · Cited by 42 · cited 4× · see citing works
“Viral translation is coupled to transcription in Sindbis virus-infected cells.”
BackgroundInfluentialThe relative translation efficiencies of reovirus messenger RNAs
Gaillard, R. K., & Jokliki, W. K. (1985) · Virology · doi:10.1016/0042-6822(85)90136-9 · Cited by 40 · cited 3× · see citing works
“References Aradaib IE, Wilson WC, Schore CE, Mohammed ME, Yilma TD, Cullor JS, Osburn BI.”
BackgroundVagnozzi, A. E., Stein, D. A., Iversen, P. L., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00557-07 · Cited by 40 · cited 1× · see citing works
“…(2008) Jia et al. (2008) Coxsackie virus B-3 Zautner et al. (2006) — Theiler’s mouse encephalitis virus — Son et al. (2008), Takano-Maruyama et al. (2006) Foot and mouth disease virus — Vagnozzi et al. (2007), Carrillo et al. (2007), Garcia-Briones et al. (2006) Bovine enterovirus — Smyth et…”
BackgroundSuperinfection exclusion in BHK-21 cells persistently infected with Junín virus
Ellenberg, P. C., Linero, F. N., & Scolaro, L. A. (2007) · Journal of General Virology · doi:10.1099/vir.0.83041-0 · Cited by 40 · cited 2× · see citing works
“Junin virus - Ellenberg et al.”
BackgroundGillet, L., Gill, M. B., Colaco, S., et al. (2006) · Journal of General Virology · doi:10.1099/vir.0.82313-0 · Cited by 39 · see citing works
Infection of Chinese Hamster Ovary Cells by Pseudorabies Virus
Nixdorf, R., Schmidt, J., Karger, A., & Mettenleiter, T. C. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8019-8026.1999 · Cited by 38 · cited 1× · see citing works
“…circovirus 1 Misinzo et al. (2006) — ds DNA Adenoviridae Adenovirus Condon et al. (2003) Hosel et al. (2003) Poxviridae Modified vaccinia virus ‘Ankara’ — Najera et al. (2006) Herpesviridae Pseudorabies virus Nixdorf et al. (1999) Slivac et al. (2006) Murine gammaherpes 68 — Gillet et al.…”
BackgroundTsai, K.-N., Tsang, S.-F., Huang, C., et al. (2006) · Virus Research · doi:10.1016/j.virusres.2006.10.013 · Cited by 33 · cited 3× · see citing works
“…Bron (1997) Kiiver et al. (2008), Marsh and Bron (1997) Sindbis virus Potts (2008) Gorchakov et al. (2008), Sanz et al. (2007) Rubella virus — Malathi et al. (2001) Japanese encephalitis virus — Tsai et al. (2007), Su et al. (2002) Eastern equine encephalitis virus — Petrakova et al. (2005)…”
BackgroundNettleton, P. F., & Rweyemamu, M. M. (1980) · Archives of Virology · doi:10.1007/bf01320621 · Cited by 32 · cited 2× · see citing works
“(2007) Garnick (1996) , Nims (2006 ) Zoletto (1985 , Nettleton and Rweyemamu (1980) Viral contaminations of CHO cell-derived bulk harvests are rare, but have occurred.”
BackgroundRespiratory disease and wasting in athymic mice infected with pneumonia virus of mice.
Weir, E. C., Dg, B., Al, S., & Johnson, E. A. (1988) · PubMed · Cited by 29 · see citing works
Aujeszky’s disease virus production in disposable bioreactor
Slivac, I., Srček, V. G., Radošević, K., et al. (2006) · Journal of Biosciences · doi:10.1007/bf02704109 · Cited by 28 · cited 1× · see citing works
“…et al. (2006) — ds DNA Adenoviridae Adenovirus Condon et al. (2003) Hosel et al. (2003) Poxviridae Modified vaccinia virus ‘Ankara’ — Najera et al. (2006) Herpesviridae Pseudorabies virus Nixdorf et al. (1999) Slivac et al. (2006) Murine gammaherpes 68 — Gillet et al. (2006) Herpes simplex…”
The association of rubella virus in congenital cataract — a hospital-based study in India
Malathi, J., Therese, K. L., & Madhavan, H. N. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(01)00177-9 · Cited by 27 · cited 1× · see citing works
“…(1979) Togaviridae Semliki Forest virus Marsh and Bron (1997) Kiiver et al. (2008), Marsh and Bron (1997) Sindbis virus Potts (2008) Gorchakov et al. (2008), Sanz et al. (2007) Rubella virus — Malathi et al. (2001) Japanese encephalitis virus — Tsai et al. (2007), Su et al. (2002) Eastern equine…”
BackgroundProteasome inhibition reduces avian reovirus replication and apoptosis induction in cultured cells
Chen, Y. T., Lin, C. H., Ji, W. T., et al. (2008) · Journal of Virological Methods · doi:10.1016/j.jviromet.2008.03.016 · Cited by 26 · cited 7× · see citing works
“Reovirus 1/2/3 Nims (2006), Potts (2008) Gaillard and Joklik (1985) Avian reovirus — Chen et al. (2008), Chulu et al. (2007) Rotavirus — Lopez et al. (2006) ss DNA Parvoviridae Mice minute virus Garnick (1996), Nims (2006) Zoletto (1985), Nettleton and Rweyemamu (1980) Circoviridae Porcine circovirus 1 Misinzo et al.…”
BackgroundInfluentialConnor, J. H., McKenzie, M. O., & Lyles, D. S. (2006) · Journal of Virology · doi:10.1128/jvi.80.8.3701-3711.2006 · Cited by 26 · cited 1× · see citing works
“…et al. (2006) Newcastle disease virus — Slosaris et al. (1989) Pneumonia virus of mice — Weir et al. (1988) Rhabdoviridae Vesicular stomatitis virus Potts (2008) Connor et al. (2006) Rabies virus — Kallel et al. (2002) ss (þ) RNA Coronaviridae Bovine coronavirus Francis (2003) — Murine hepatitis…”
BackgroundSon, K., Becker, R. P., Kallio, P. D., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02349-07 · Cited by 25 · cited 1× · see citing works
“…et al. (2003), Genzyme (2009) — Picornaviridae Encephalomyocarditis virus Potts (2008) Jia et al. (2008) Coxsackie virus B-3 Zautner et al. (2006) — Theiler’s mouse encephalitis virus — Son et al. (2008), Takano-Maruyama et al. (2006) Foot and mouth disease virus — Vagnozzi et al. (2007),…”
BackgroundJia, H., Ge, X., Guo, X., et al. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.12.003 · Cited by 22 · cited 2× · see citing works
“…(2003) St. Louis encephalitis virus — McLean et al. (1978) Caliciviridae Vesivirus 2117 Oehmig et al. (2003), Genzyme (2009) — Picornaviridae Encephalomyocarditis virus Potts (2008) Jia et al. (2008) Coxsackie virus B-3 Zautner et al. (2006) — Theiler’s mouse encephalitis virus — Son et al.…”
BackgroundConner, J., Rixon, F. J., & Brown, S. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9970-9981.2005 · Cited by 20 · cited 1× · see citing works
“…Poxviridae Modified vaccinia virus ‘Ankara’ — Najera et al. (2006) Herpesviridae Pseudorabies virus Nixdorf et al. (1999) Slivac et al. (2006) Murine gammaherpes 68 — Gillet et al. (2006) Herpes simplex virus 1 — Conner et al. (2005) Iridoviridae Frog virus 3 — Chinchar et al. (2003) Berting…”
BackgroundMatsuyama, S., & Taguchi, F. (2000) · Virology · doi:10.1006/viro.2000.0409 · Cited by 19 · cited 4× · see citing works
“Bovine viral diarrhea virus (BVDV), Coxsackievirus B3 (CVB3), Murine hepatitis virus (MHV), Pseudorabies virus (PRV) and Porcine parvovirus (PPV) did not induce a CPE in CHO cell culture (Fig.”
BackgroundInfluentialBovine enterovirus as an oncolytic virus: Foetal calf serum facilitates its infection of human cells
Smyth, M., Symonds, A. L. J., Brazinova, S., et al. (2002) · International Journal of Molecular Medicine · doi:10.3892/ijmm.10.1.49 · Cited by 19 · cited 3× · see citing works
“…virus — Son et al. (2008), Takano-Maruyama et al. (2006) Foot and mouth disease virus — Vagnozzi et al. (2007), Carrillo et al. (2007), Garcia-Briones et al. (2006) Bovine enterovirus — Smyth et al. (2002) Porcine enterovirus — Knowles et al. (1979) Togaviridae Semliki Forest virus Marsh and…”
BackgroundAradaib, I. E., Wilson, W. C., Schore, C. E., et al. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.9.2604-2608.1998 · Cited by 16 · cited 2× · see citing works
“(1993) Aradaib et al. (1998)”
BackgroundDevelopment of a Chinese Hamster Ovary Cell Line for Recombinant Adenovirus‐Mediated Gene Expression
Condon, R. G. G., Schaefer, E. J., Santoro, M., Longley, R., Tsao, Y., Zurawski, S. M., & Liu, Z. (2003) · Biotechnology Progress · doi:10.1021/bp0200696 · Cited by 15 · cited 4× · see citing works
“…(2006) ss DNA Parvoviridae Mice minute virus Garnick (1996), Nims (2006) Zoletto (1985), Nettleton and Rweyemamu (1980) Circoviridae Porcine circovirus 1 Misinzo et al. (2006) — ds DNA Adenoviridae Adenovirus Condon et al. (2003) Hosel et al. (2003) Poxviridae Modified vaccinia virus ‘Ankara’ —…”
BackgroundResultInfluentialSlosaris, M., Levy, B., Katz, E., et al. (1989) · Avian Diseases · doi:10.2307/1590839 · Cited by 15 · cited 3× · see citing works
“(2008) Coxsackie virus B-3 Zautner et al. (2006) — Theiler’s mouse encephalitis virus — Son et al.”
BackgroundTakano‐Maruyama, M., Ohara, Y., Asakura, K., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00693-06 · Cited by 14 · cited 1× · see citing works
“…(2009) — Picornaviridae Encephalomyocarditis virus Potts (2008) Jia et al. (2008) Coxsackie virus B-3 Zautner et al. (2006) — Theiler’s mouse encephalitis virus — Son et al. (2008), Takano-Maruyama et al. (2006) Foot and mouth disease virus — Vagnozzi et al. (2007), Carrillo et al. (2007),…”
BackgroundEffects of Ribavirin on BHK-21 Cells Acutely or Persistently Infected With Mumps Virus
McCammon, J. R., & Riesser, V. W. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.15.3.356 · Cited by 12 · cited 5× · see citing works
“We thank Barbara Potts for raising our interest in the subject and for initial discussions.”
BackgroundInfluentialKiiver, K., Merits, A., & Sarand, I. (2007) · Virus Research · doi:10.1016/j.virusres.2007.08.008 · Cited by 12 · cited 2× · see citing works
“…Carrillo et al. (2007), Garcia-Briones et al. (2006) Bovine enterovirus — Smyth et al. (2002) Porcine enterovirus — Knowles et al. (1979) Togaviridae Semliki Forest virus Marsh and Bron (1997) Kiiver et al. (2008), Marsh and Bron (1997) Sindbis virus Potts (2008) Gorchakov et al. (2008), Sanz et…”
BackgroundThe Abortive Infection of Syrian Hamster Cells with Human Adenovirus Type 12
Hösel, M., Webb, D., Schröer, J., et al. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05597-7_14 · Cited by 11 · cited 3× · see citing works
“Although experimental infection of CHO cells with Porcine circovirus, a member of the Circoviridae, has been shown (Misinzo et al., 2006), this virus was not included in the present screen, as the previously published experiments showed no productive replication in CHO cells and no substantial safety concerns are ther…”
BackgroundTransmission of Northway and St. Louis encephalitis viruses by arctic mosquitoes
McLean, D. M., Grass, P. N., Judd, B. D., et al. (1978) · Archives of Virology · doi:10.1007/bf01320071 · Cited by 11 · cited 2× · see citing works
“2010 Wiley Periodicals, Inc. Potts (2008) Bunyamwera virus — Salanueva et al. (2003) Northway encephalitis virus — McLean et al. (1978) Orthomyxoviridae Influenza A/B virus Kumari et al. (2007), Chu and Whittaker (2004) Govorkova et al. (1999) Arenaviridae Junin virus — Ellenberg et al. (2007)…”
BackgroundLópez, T., López, S., & Arias, C. F. (2006) · Virus Research · doi:10.1016/j.virusres.2006.04.006 · Cited by 10 · cited 1× · see citing works
“…hemorrhagic disease virus Rabenau et al. (1993) Aradaib et al. (1998) Reovirus 1/2/3 Nims (2006), Potts (2008) Gaillard and Joklik (1985) Avian reovirus — Chen et al. (2008), Chulu et al. (2007) Rotavirus — Lopez et al. (2006) ss DNA Parvoviridae Mice minute virus Garnick (1996), Nims (2006)…”
Background(2004) · PubMed · Cited by 9 · see citing works
A New Indicator Cell Line to Monitor Human Foamy Virus Infection and Stability in vitro
Li, Z., Yang, P., Liu, H., et al. (2002) · Intervirology · doi:10.1159/000063232 · Cited by 8 · cited 1× · see citing works
“…et al. (2005) Venezuelan equine encephalitis virus — Petrakova et al. (2005) Arteriviridae Porcine reproductive and respiratory syndrome virus — Shanmukhappa et al. (2007) Retroviridae Foamy virus — Li et al. (2002) ds RNA Reoviridae Bluetongue virus Potts (2008) De et al. (2005) Epizootic…”
BackgroundZoletto, R. (1985) · PubMed · Cited by 8 · see citing works
Plaque formation by human-origin parainfluenza type 2 virus in established cell lines
Shimokata, K., Ito, Y., Nishiyama, Y., et al. (1981) · Archives of Virology · doi:10.1007/bf01314839 · Cited by 7 · cited 2× · see citing works
“(2008) Coxsackie virus B-3 Zautner et al. (2006) — Theiler’s mouse encephalitis virus — Son et al.”
BackgroundNishio, M., Nagata, A., Yamamoto, A., et al. (2006) · Medical Microbiology and Immunology · doi:10.1007/s00430-006-0012-3 · Cited by 5 · cited 3× · see citing works
“…(2008) He et al. (2002) Mumps virus Wisher (2005), Potts (2008) McCammon and Riesser (1979) Bovine respiratory syncytial virus Potts (2008) — Sendai virus — Nishio et al. (2006) Newcastle disease virus — Slosaris et al. (1989) Pneumonia virus of mice — Weir et al. (1988) Rhabdoviridae Vesicular…”
Background
Flagged first, then by citations
1 of the 70 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Genzyme.2009.Genzyme temporarily interrupts production at Allston plant. Press release June 16 2009; available athttp://www.genzyme.com/corp/media/GENZ%20PR‐061609.asp(last accessed January 21 2010).
Cited by
Sorted by citations
Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
Dumont, J., Euwart, D., Mei, B., Estes, S., & Kshirsagar, R. (2016) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1084266 · Cited by 483 · see citing works
“Further, there is perceived species barrier protection with the use of hamster-derived cells, reducing the potential risk of transfer of contaminating adventitious agents to humans (Berting et al., 2010; Swiech et al., 2012).”
BackgroundImpact of host cell line choice on glycan profile
Goh, J. B., & Ng, S. K. (2017) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2017.1416577 · Cited by 226 · see citing works
Pereira, S., Kildegaard, H. F., & Andersen, M. R. (2018) · Biotechnology Journal · doi:10.1002/biot.201700499 · Cited by 214 · see citing works
“In addition, CHO cells have been demonstrated to display reduced susceptibility to human viral infections [11], which represents an additional advantage over cell lines of human”
BackgroundMicrobial protein cell factories fight back?
Rettenbacher, L. A., Arauzo-Aguilera, K., Buscajoni, L., Castillo-Corujo, A., Ferrero-Bordera, B., Kostopoulou, A., Moran-Torres, R., Núñez-Nepomuceno, D., Öktem, A., Palma, A., et al. (2021) · Trends in Biotechnology · doi:10.1016/j.tibtech.2021.10.003 · Cited by 59 · see citing works
Hansen, H. G., Pristovšek, N., Kildegaard, H. F., & Lee, G. M. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.11.008 · Cited by 72 · see citing works
“Third, CHO cells are less prone to virus infection than other mammalian production cell lines and are therefore regarded as a safe host for the production of human therapeutics (Berting et al., 2010).”
BackgroundMultivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection
Petitjean, S. J. L., Chen, W., Koehler, M., Jimmidi, R., Yang, J., Mohammed, D., Juniku, B., Stanifer, M. L., Boulant, S., Vincent, S. P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30313-8 · Cited by 70 · see citing works
Improving Immunotherapy Through Glycodesign
Buettner, M. J., Shah, S. R., Saeui, C. T., Ariss, R., & Yarema, K. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02485 · Cited by 66 · see citing works
“From a safety perspective, many viral entry genes are not expressed in CHO cells and there is a species barrier that minimizes risk of transferring infectious agents to humans (325, 326).”
BackgroundNew Insights into Cell Culture Technology
Gowder, S. J. (2017) · InTech eBooks · doi:10.5772/62590 · Cited by 67 · see citing works
Moody, M. D., Alves, W., Varghese, J., & Khan, F. (2011) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2011.00824 · Cited by 54 · see citing works
Metagenomic assessment of adventitious viruses in commercial bovine sera
Toohey-Kurth, K. L., Sibley, S. D., & Goldberg, T. L. (2017) · Biologicals · doi:10.1016/j.biologicals.2016.10.009 · Cited by 49 · see citing works
“For example, diverse viruses have been identified as contaminants of Chinese hamster ovary cells, which are widely used in biologics manufacturing [46].”
BackgroundWindyga, J., Lissitchkov, T. J., Stasyshyn, O., Mamonov, V. E., Rusen, L., Lamas, J. L., Oh, M., Chapman, M., Fritsch, S. R. S., Pavlova, B. G., et al. (2013) · Haemophilia · doi:10.1111/hae.12228 · Cited by 48 · see citing works
Reexamining opportunities for therapeutic protein production in eukaryotic microorganisms
Matthews, C. B., Wright, C. M., Kuo, A., Colant, N., Westoby, M., & Love, J. C. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26378 · Cited by 48 · see citing works
Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation Studies
Gefroh, E., Dehghani, H., McClure, M., Connell‐Crowley, L., & Vedantham, G. (2014) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2014.00978 · Cited by 47 · see citing works
Matrix and Backstage: Cellular Substrates for Viral Vaccines
Jordan, I., & Sandig, V. (2014) · Viruses · doi:10.3390/v6041672 · Cited by 43 · see citing works
“As opposed to BHK, this cell line derived from an inbred (captive) female Chinese hamster (Cricetulus griseus) [84] is not permissive for many viruses [85–87].”
BackgroundPoulain, A., Mullick, A., Bernard Massie, B., & Durocher, Y. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.03.009 · Cited by 39 · see citing works
Baumann, M., Gludovacz, E., Sealover, N. R., Bahr, S. M., George, H. J., Lin, N., Kayser, K. J., & Borth, N. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26388 · Cited by 39 · see citing works
Passage of soft pathogens through microfiltration membranes scales with transmembrane pressure
Helling, A., Kubicka, A., Schaap, I. A. T., et al. (2016) · Journal of Membrane Science · doi:10.1016/j.memsci.2016.08.016 · Cited by 38 · see citing works
Chin, C. L., Chin, H. K., Chin, C. S. H., Lai, E. T., & Ng, S. K. (2015) · BMC Biotechnology · doi:10.1186/s12896-015-0145-9 · Cited by 37 · see citing works
“In addition to its ability to produce glycoproteins with post-translational modifications compatible to humans [1], and its refractory nature to human viruses [2], the availability of well-established gene amplification systems for CHO cells coupled with its ability to adapt and grow in serum-free suspension culture m…”
BackgroundYeo, J. H. M., Ho, S. C. L., Mariati, M., Koh, E. Y. C., Tay, S. J., Woen, S., Zhang, P., & Yang, Y. (2017) · Biotechnology Journal · doi:10.1002/biot.201700175 · Cited by 34 · see citing works
CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering
Glinšek, K., Bozovičar, K., & Bratkovič, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098144 · Cited by 35 · see citing works
“As pointed out in the introduction, one of the reasons for the extensive adoption of CHO cells in the biopharmaceutical industry is their reduced susceptibility to human viruses [103].”
BackgroundIndustrial production of clotting factors: challenges of expression, and choice of host cells
Kumar, S. R. (2015) · Biotechnology Journal · doi:10.1002/biot.201400666 · Cited by 31 · see citing works
Qiu, Y., Jones, N., Busch, M., Pan, P., Keegan, J., Zhou, W., Plavsic, M., Hayes, M., McPherson, J. M., Edmunds, T., et al. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24791 · Cited by 29 · see citing works
“Current adventitious agent testing (AAT) assays are effective for the detection of viruses which are able to replicate in CHO cells (Berting et al., 2010).”
BackgroundMarx, N., Eisenhut, P., Weinguny, M., Klanert, G., & Borth, N. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.107924 · Cited by 29 · see citing works
Combating viral contaminants in CHO cells by engineering innate immunity
Chiang, A. W. T., Li, S., Kellman, B. P., Chattopadhyay, G., Zhang, Y., Kuo, C., Gutierrez, J. M., Ghazi, F., Schmeisser, H., Ménard, P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45126-x · Cited by 21 · see citing works
New Mammalian Expression Systems
Zhu, J., & Hatton, D. (2017) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2016_55 · Cited by 21 · see citing works
Rodriguez, S. P., Wulff, T., Voldborg, B. G. R., Altamirano, C., Trujillo‐Roldán, M. A., & Valdez‐Cruz, N. A. (2021) · ACS Omega · doi:10.1021/acsomega.0c06030 · Cited by 20 · see citing works
Pérez-Rodríguez, S., Ramírez, O. T., Trujillo-Roldán, M., & Valdez-Cruz, N. A. (2020) · Electronic Journal of Biotechnology · doi:10.1016/j.ejbt.2020.09.006 · Cited by 17 · see citing works
“Among them, CHO cells are the preferred host due to the advantages that they offer in terms of growth [63,64,65], productivity [3], specific culture mediums [66], safety [67], and product quality [68].”
BackgroundTejwani, V., Chaudhari, M., Rai, T., & Sharfstein, S. T. (2021) · Biotechnology Progress · doi:10.1002/btpr.3208 · Cited by 19 · see citing works
Evaluating ultraviolet sensitivity of adventitious agents in biopharmaceutical manufacturing
Meunier, S. M., Sasges, M. R., & Aucoin, M. G. (2017) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-017-1917-0 · Cited by 19 · see citing works
SARS-CoV-2 and the safety margins of cell-based biological medicinal products
Modrof, J., Kerschbaum, A., Farcet, M. R., et al. (2020) · Biologicals · doi:10.1016/j.biologicals.2020.08.010 · Cited by 18 · see citing works
“A general concern in cell-based manufacturing of recombinant proteins, including vaccines, is the potential contamination of the cell culture with viruses, which has had severe consequences for patients and manufacturers [1,2].”
Self-citationMöller, J., & Pörtner, R. (2017) · InTech eBooks · doi:10.5772/67600 · Cited by 18 · see citing works
“To ensure the safety of biological therapeutics, regulatory guidance requires adventitious agent testing of the bulk harvest [10].”
BackgroundWindyga, J., Trujillo, M. H. S., & Hafeman, A. E. (2014) · Therapeutic Advances in Hematology · doi:10.1177/2040620714550573 · Cited by 17 · see citing works
Leisi, R., Wolfisberg, R., Nowak, T., et al. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27555 · Cited by 17 · see citing works
Dodkins, R., Delaney, J. R., Overton, T., Scholle, F., Frias‐De‐Diego, A., Crisci, E., Huq, N., Jordan, I., Kimata, J. T., Findley, T., et al. (2023) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2023.07.003 · Cited by 15 · see citing works
Animal Cell Lines as Expression Platforms in Viral Vaccine Production: A Post Covid-19 Perspective
Demirden, S. F., Gebologlu, I. K., & Öncel, S. Ş. (2024) · ACS Omega · doi:10.1021/acsomega.3c10484 · Cited by 15 · see citing works
Noncoding RNAs, post-transcriptional RNA operons and Chinese hamster ovary cells
Stiefel, F., Fischer, S., Hackl, M., Handrick, R., Hesse, F., Borth, N., Otte, K., & Grillari, J. (2015) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.14.65 · Cited by 15 · see citing works
The Art of Animal Cell Culture for Virus Isolation
John, A., & Diane, E. (2012) · InTech eBooks · doi:10.5772/51215 · Cited by 15 · see citing works
“MMV is a notorious contaminant of rodent cell lines important for the biopharmaceutical industry [67].”
BackgroundThe potential of emerging sub-omics technologies for CHO cell engineering
Jerabek, T., Keysberg, C., & Otte, K. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.107978 · Cited by 14 · see citing works
Maltais, J., Lord‐Dufour, S., Morasse, A., Stuible, M., Loignon, M., & Durocher, Y. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28435 · Cited by 14 · see citing works
Detection of Adventitious Agents Using Next-Generation Sequencing
Richards, B., Cao, S., Plavsic, M., Pomponio, R. J., Davies, C., Mattaliano, R. J., Madden, S. F., Klinger, K., & Palermo, A. (2014) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2014.01025 · Cited by 14 · see citing works
“contamination in CHO cell cultures, with some incidents affecting bulk harvests from production runs (7).”
BackgroundAmadi, I., Agrawal, V., Christianson, T., et al. (2020) · Biotechnology Progress · doi:10.1002/btpr.2974 · Cited by 13 · see citing works
“Among mammalian cells, CHO cells most often represent the mammalian cell of choice for their ease of use, reduced susceptibility to viral infection, and familiarity with biologics regulators.(30,31) However, due to growing demand and development of DTE recombinant proteins such as bispecific antibodies, fusion protein…”
BackgroundMeunier, S. M., Todorovic, B., Dare, E. V., Begum, A., Guillemette, S. R., Wenger, A., Saxena, P., Campbell, J. L., Sasges, M. R., & Aucoin, M. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150957 · Cited by 12 · see citing works
“MMV, a common virus in laboratory mice that can replicate in CHO cell lines [16], has a D10 value of approximately 2.”
BackgroundDuroy, P., Bosshard, S., Schmid‐Siegert, E., Neuenschwander, S., Arib, G., Mercier, P. L., Masternak, J., Roesch, L., Buron, F., Girod, P., et al. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27200 · Cited by 12 · see citing works
“For instance, it was shown that CHO cells possess reduced susceptibility to certain viral infections (Berting et al., 2010).”
MacDonald, M. L., Polson, S. W., & Lee, K. H. (2021) · mSphere · doi:10.1128/msphere.01336-20 · Cited by 11 · see citing works
Genetic engineering of CHO cells for viral resistance to minute virus of mice
Mascarenhas, J., Korokhov, N., Burger, L. R., Kassim, A., Tuter, J., Miller, D., Borgschulte, T., George, H. J., Chang, A., Pintel, D. J., et al. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26186 · Cited by 11 · see citing works
“…the risk of introducing adventitious agents, such as control of the raw material source, testing for adventitious agents in raw materials and the bulk harvest at appropriate stages during the manufacturing process, and implementation of virus-inactivation and removal steps (Berting et al., 2010).”
BackgroundInfluentialValiant, W. G., Cai, K., & Vallone, P. M. (2022) · Biologicals · doi:10.1016/j.biologicals.2022.10.002 · Cited by 12 · see citing works
Marco, F. D., Sebastian, I. R., Napoleone, A., Molin, A., Riedl, M., Bydlinski, N., Motheramgari, K., Hussein, M. K., Kramer, L., Kelly, T. J., et al. (2025) · Metabolic Engineering · doi:10.1016/j.ymben.2025.08.007 · Cited by 9 · see citing works
Conley, M., Emmott, E., Orton, R., Taylor, D., Carneiro, D. G., Murata, K., Goodfellow, I. G., Hansman, G. S., & Bhella, D. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000658 · Cited by 8 · see citing works
“…agent testing is mandated for the prevention of contamination by viruses able to replicate in CHO cells and has led to the detection of five incidents in the past 20 years caused by murine minute virus, reovirus, Cache Valley virus, epizootic hemorrhagic disease virus and vesivirus 2117 [18 – 23].”
Error propagation in constraint‐based modeling of Chinese hamster ovary cells
Széliová, D., Iurashev, D., Ruckerbauer, D. E., Koellensperger, G., Borth, N., Melcher, M., & Zanghellini, J. (2020) · Biotechnology Journal · doi:10.1002/biot.202000320 · Cited by 7 · see citing works
“[i] = [î] + "c with "c ∼ (0, 2 c ) (2) where "c is a standard normal random variable with relative standard deviation (RSD) c∕[î] chosen between 0.”
BackgroundApplication of Genetic Engineering in Biotherapeutics Development
Schweickert, P. G., & Cheng, Z. (2019) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-019-09411-6 · Cited by 7 · see citing works
“CHO cells are refractory to viral infection from most human pathogens [46] and can produce glycopro te ins that a re both bioac t ive and nonimmunogenic in human hosts [47].”
BackgroundTowards Enhancing Therapeutic Glycoprotein Bioproduction: Interventions in the PI3K/AKT/mTOR Pathway
Mahameed, M., Sulieman, A., Alkam, D., & Tirosh, B. (2019) · Cell Structure and Function · doi:10.1247/csf.19013 · Cited by 6 · see citing works
The Role of Rixubis™ in the Treatment of Hemophilia B
Valentino, L. A. (2014) · Immunotherapy · doi:10.2217/imt.14.17 · Cited by 6 · see citing works
Sukwattananipaat, P., Kuroda, H., Yamano, N., & Ōmasa, T. (2024) · Biotechnology and Bioengineering · doi:10.1002/bit.28777 · Cited by 5 · see citing works
“CHO cell lines are widely used because of their attractive attributes, including protein modification and glycosylation, invulnerability to several human pathogenic viruses, serum ‐ free adaptation, and scale ‐ up capabilities (Berting et al., 2010; Omasa et al., 2010).”
Protein Production in Eukaryotic Cells
Ram, K., Hatton, D., Ahuja, S., Bender, J., Hunter, A. K., & Turner, R. C. (2016) · Topics in medicinal chemistry · doi:10.1007/7355_2016_3 · Cited by 5 · see citing works
Retrovectors packaged in CHO cells to generate GLP-1-Fc stable expression CHO cell lines
Li, J., Wei, S., Cao, C., et al. (2019) · Electronic Journal of Biotechnology · doi:10.1016/j.ejbt.2019.07.002 · Cited by 5 · see citing works
“CHO cells are permissive to multiple types of viruses such as Adenovirus, Parainfluenza virus, Bovine respiratory syncytial virus, Vesicular stomatitis virus, Reovirus, and Bluetongue virus [14].”
Hayes, P. R., Przybycien, T. M., & Schneider, J. W. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27957 · Cited by 5 · see citing works
“These results were consistent with the virus susceptibility of CHO cells reported by Berting et al. (2010).”
ResultViral inactivation for pH-sensitive antibody formats such as multi-specific antibodies.
Duret, A., Duarte, L., Cahuzac, L., Rondepierre, A., Lambercier, M., Mette, R., Recktenwald, A., Giovannini, R., & Bertschinger, M. (2024) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2024.02.009 · Cited by 4 · see citing works
Chiu, K., & Du, D. (2024) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-024-00141-2 · Cited by 5 · see citing works
“In particular, CHO cells have low susceptibility to many human virus families [2] such as influenza and HIV, which greatly reduces the threat of contamination to the supply of critical drugs [3].”
Expression, Purification, and Evaluation of Anti-IL-2Rα Antibody Secreted by Leishmania tarentolae
Jalali, A., Bandehpour, M., Chegeni, R., et al. (2020) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-020-10088-6 · Cited by 4 · see citing works
Sirasitthichoke, C., Hoang, D. M., Phalak, P., et al. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28264 · Cited by 4 · see citing works
“…posttranslational modifications similar to human proteins, which are offered by the CHO cellular machinery in the secreted target proteins, makes CHO the preferred production host over other mammalian systems in the biopharmaceutical industry (Berting et al., 2010; Spier, 1989).”
BackgroundNapoleone, A., Sebastian, I. R., Marco, F. D., Molin, A., Hussein, M., Kramer, L., Jostock, T., Kelly, T., & Borth, N. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201678 · Cited by 3 · see citing works
“42,54 This resistance, while advantageous for ensuring the safety of biotherapeutics, poses unique limitations for effective viral-vector-based transgene delivery.”
Safety Assurance for Biologics Manufactured in Mammalian Cell Cultures: A Multitiered Strategy
Chen, D. (2013) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2013_213 · Cited by 3 · see citing works
“For example, CHO cells are susceptible to many different viruses belonging to a dozen or so families based on existing studies [26–28].”
BackgroundLotfi, M. S., Jafari, S., Razmyeki, M., et al. (2026) · Methods · doi:10.1016/j.ymeth.2026.05.012 · Cited by 2 · see citing works
Chinese Hamster Ovary Cell Line Instability: Causes, Mitigation, and Prediction
Joo, Y., Kim, H., & Baik, J. Y. (2023) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-023-0120-6 · Cited by 2 · see citing works
“Finally, they have lower susceptibility to human viruses, making them an ideal host for biopharmaceutical production [6].”
BackgroundKitamura, R., Enghauser, L., Miyamoto, R., et al. (2024) · Biotechnology Progress · doi:10.1002/btpr.3516 · Cited by 2 · see citing works
Parallel Evaluation of Broad Virus Detection Methods
Modrof, J., Berting, A., & Kreil, T. R. (2014) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2014.01014 · Cited by 2 · see citing works
Self-citationMeeting Report: 2013 PDA Virus & TSE Safety Forum
Willkommen, H., Blümel, J., Brorson, K., Chen, D. A., Chen, Q., Gröner, A., Hubbard, B. R., Kreil, T. R., Ruffing, M., Ruiz, S., et al. (2014) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2014.00980 · Cited by 2 · see citing works
“The intention of the latter was to understand the value of each of the test methods in detecting potential adventitious agents, similar to a more limited study earlier (34), as well as to provide”
Self-citationGemmell, D. K., Mack, A. A., Wegmann, S., Han, D., Tuccelli, R., Johnson, M., & Miller, C. (2021) · Engineering in Life Sciences · doi:10.1002/elsc.202100044 · Cited by 1 · see citing works
“Approximately 70% of all biotech products are produced by Chinese Hamster Ovary (CHO) cell lines [11] which are typically more resilient than other alternative expression systems [12].”
BackgroundGrimes, M. I., & Mantle, M. D. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781788019996-00244 · Cited by 1 · see citing works
Exploiting non-permissive CHO cells as a rapid and efficient method for recombinant HSV-1 isolation
Kelishadi, M., Shahsavarani, H., Tabarraei, A., et al. (2024) · AMB Express · doi:10.1186/s13568-024-01709-0 · Cited by 1 · see citing works
“These can include Adenovirus, Vesicular stomatitis virus, Reovi-rus, Parainfluenza virus, Bovine respiratory syncytial virus, and Bluetongue virus (Berting et al. 2010).”
BackgroundInfluentialCultivation of the CHO Cell Line in Bioreactors of Various Volumes: Technological Optimization
Кирилин, А. В., Цветкова, И. И., Sarbasov, A. B., Романова, П. Ю., Цирулева, М. А., Гузов, Е. А., Саповская, В. В., Ерхов, А. В., Афанасьев, М. С., Исеркапов, А. В., et al. (2025) · Applied Biochemistry and Microbiology · doi:10.1134/s000368382570053x · Cited by 1 · see citing works
“In addition, CHO cells have reduced susceptibility to human viral infections, which is an additional advantage compared to human-derived cell lines [3].”
Hasheminejad, F., Norouzi, H., Jazayeri, S. H., Halfinezhad, Z., Daneshipour, A., Khoshnood, Z., Nejati, M., Norouzi, F., Abolghasemi, S., Gharanfoli, M., et al. (2026) · Biotechnology Letters · doi:10.1007/s10529-026-03707-7 · Cited by 1 · see citing works
“…hamster ovary (CHO) cells are widely used as mammalian hosts for the production of recombinant biopharmaceutical proteins, particularly glycoproteins that require human-like post-translational modifications (PTMs) (Berting et al. 2010; Butler and Spearman 2014; Walsh 2018; Zhu and Hatton 2018).”
Lindskog, E. K., Fischer, S., Wenger, T., & Schulz, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-100623-8.00006-2 · Cited by 1 · see citing works
Mousavi, S. M. R.-N., Hosseini, S. M., & Ansari, S. (2023) · Iranian Journal of Microbiology · doi:10.18502/ijm.v15i5.13877 · Cited by 1 · see citing works
Chin, C. L., Chin, H. K., Chin, C. S. H., Lai, E. T., & KongNg, S. (2015) · BMC Proceedings · doi:10.1186/1753-6561-9-s9-p10 · Cited by 1 · see citing works
“In addition to its ability to produce glycoproteins with post-translational modifications compatible to humans [1], and its refractory nature to human viruses [2], the availability of well-established gene amplification systems for CHO cells coupled with its ability to adapt and grow in serum-free suspension culture m…”
BackgroundA Mechanistic Dissection of Polyethylenimine Mediated Transfection of Chinese Hamster Ovary Cells
Mozley, O. L. (2013) · Cited by 1 · see citing works
(2010) · Biotechnology Journal · doi:10.1002/biot.201000225 · Cited by 1 · see citing works
Forty Years of Innovation in Biopharmaceuticals – Will the Next 40 Years Be as Revolutionary?
Schmidt, M., Patel, S. K. S., Veiby, P. O., Liu, Q., & Buckley, M. (2016) · doi:10.1002/9783527693405.ch12
Cell Line Development for Biomanufacturing Processes
Gadgil, M., & Hu, W. (2017) · doi:10.1002/9783527800599.ch12
Wieser, A., Modrof, J., & Kreil, T. R. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28473
Self-citationExpression and purification of inclusion body of Serratia marcescens nuclease relying on SUMO fusionPreprint
Zang, M., Wei, Y., Deng, L., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3333915/v1
Hsu, T. Y., Talley, M. J., Yang, P., Geiselhoeringer, A., Yang, C. L.-H., Gorla, A., Rahman, M. J., Silva, L., Chen, D., & Yang, B. (2024) · Biotechnology Progress · doi:10.1002/btpr.3485
“68,118 Lastly, some medium risk viruses complete the full life cycle, but do so poorly.”
InfluentialCharacterization of Chemically-Induced Endogenous Retroviral Particles in the CHO-K1 Cell Line
Mattson, N., Bosma, T. J., Gao, Y. S., et al. (2025) · Viruses · doi:10.3390/v17111408
“…derivatives are a popular cell–substrate for the production of biotherapeutic protein products due to the restricted susceptibility of the cell line to infection by human viruses [56] and easy scale-up to produce proteins with human-like glycosylation and other post-translational modifications [3].”
Staniszewska, A., & Piastowska‐Ciesielska, A. W. (2026) · Methods and Protocols · doi:10.3390/mps9040107
“Most documented events in CHO-derived products involved mouse minute virus, reovirus, Cache Valley virus, epizootic hemorrhagic disease virus, and vesivirus 2117, usually traced to raw materials like animal serum or media components [1,3–5].”
Hong, R., Blanda, T. R., Bednar, M., et al. (2026) · Biotechnology Progress · doi:10.1002/btpr.88561
Fieder, J., Schneider, S., & Fischer, S. (2026) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2026.2738418
- Authors
- Berting, A., Farcet, M. R., & Kreil, T. R.
- Affiliations
- Baxter (Austria) (AT)
- Corresponding author
- Kreil, Thomas R.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2010-04-08
- Volume
- 106
- Issue
- 4
- Pages
- 598-607
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- PMC
- PMC7161873
- OpenAlex
- W2101010021
- Semantic Scholar
- 7297a33202f8f67226ce974a662dae282b1a728d
- Cited by
- 88
- References
- 70
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 8 · 2023: 7 · 2022: 7 · 2021: 6 · 2020: 6 · 2019: 6 · 2018: 3 · 2017: 10 · 2016: 7 · 2015: 5 · 2014: 7 · 2013: 3 · 2012: 2
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biotechnology and Bioengineering (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- CHO cells, viral susceptibility, viral contamination, biopharmaceutical manufacturing, pathogen safety, cytopathic effect, viral replication, biologic therapy
- MeSH terms
- Animals, Cricetulus, Drug Contamination, Cricetinae, Technology, Pharmaceutical, Viruses, CHO Cells, Cell Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-28.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review